166 related articles for article (PubMed ID: 22713244)
21. The Herculean task of killing cancer cells: suppression of FOXO3A in acute leukemia involves a hydra of multiple survival kinases.
Ruvolo PP
Cell Cycle; 2012 Jul; 11(14):2589. PubMed ID: 22751430
[TBL] [Abstract][Full Text] [Related]
22. Activation of PI3K/Akt/IKK-alpha/NF-kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin.
Sun ZJ; Chen G; Hu X; Zhang W; Liu Y; Zhu LX; Zhou Q; Zhao YF
Apoptosis; 2010 Jul; 15(7):850-63. PubMed ID: 20386985
[TBL] [Abstract][Full Text] [Related]
23. Abelson virus transformation prevents TRAIL expression by inhibiting FoxO3a and NF-kappaB.
Wilson MK; McWhirter SM; Amin RH; Huang D; Schlissel MS
Mol Cells; 2010 Apr; 29(4):333-41. PubMed ID: 20213318
[TBL] [Abstract][Full Text] [Related]
24. FOXO3a mediates the cytotoxic effects of cisplatin in lung cancer cells.
Liu H; Yin J; Wang C; Gu Y; Deng M; He Z
Anticancer Drugs; 2014 Sep; 25(8):898-907. PubMed ID: 24814195
[TBL] [Abstract][Full Text] [Related]
25. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.
Li Z; Yang Z; Passaniti A; Lapidus RG; Liu X; Cullen KJ; Dan HC
Oncotarget; 2016 May; 7(22):31892-906. PubMed ID: 26895469
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of type I interferon-mediated antiviral action in human glioma cells by the IKK inhibitors BMS-345541 and TPCA-1.
Du Z; Whitt MA; Baumann J; Garner JM; Morton CL; Davidoff AM; Pfeffer LM
J Interferon Cytokine Res; 2012 Aug; 32(8):368-77. PubMed ID: 22509977
[TBL] [Abstract][Full Text] [Related]
27. Harmine Hydrochloride Mediates the Induction of G2/M Cell Cycle Arrest in Breast Cancer Cells by Regulating the MAPKs and AKT/FOXO3a Signaling Pathways.
Ock CW; Kim GD
Molecules; 2021 Nov; 26(21):. PubMed ID: 34771123
[TBL] [Abstract][Full Text] [Related]
28. Butein inhibits cell proliferation and induces cell cycle arrest in acute lymphoblastic leukemia via FOXO3a/p27kip1 pathway.
Tang YL; Huang LB; Lin WH; Wang LN; Tian Y; Shi D; Wang J; Qin G; Li A; Liang YN; Zhou HJ; Ke ZY; Huang W; Deng W; Luo XQ
Oncotarget; 2016 Apr; 7(14):18651-64. PubMed ID: 26919107
[TBL] [Abstract][Full Text] [Related]
29. The IKK inhibitor BMS-345541 affects multiple mitotic cell cycle transitions.
Blazkova H; von Schubert C; Mikule K; Schwab R; Angliker N; Schmuckli-Maurer J; Fernandez PC; Doxsey S; Dobbelaere DA
Cell Cycle; 2007 Oct; 6(20):2531-40. PubMed ID: 17704647
[TBL] [Abstract][Full Text] [Related]
30. Protein kinase C downregulation induces senescence via FoxO3a inhibition in HCT116 and HEK293 cells.
Park JW; Lee YH; Bae YS
Biochem Biophys Res Commun; 2017 Dec; 493(4):1548-1554. PubMed ID: 28989024
[TBL] [Abstract][Full Text] [Related]
31. U2AF1 mutation promotes tumorigenicity through facilitating autophagy flux mediated by FOXO3a activation in myelodysplastic syndromes.
Zhu Y; Song D; Guo J; Jin J; Tao Y; Zhang Z; Xu F; He Q; Li X; Chang C; Wu L
Cell Death Dis; 2021 Jun; 12(7):655. PubMed ID: 34183647
[TBL] [Abstract][Full Text] [Related]
32. Anticancer activity of cryptotanshinone on acute lymphoblastic leukemia cells.
Wu CF; Klauck SM; Efferth T
Arch Toxicol; 2016 Sep; 90(9):2275-2286. PubMed ID: 26564229
[TBL] [Abstract][Full Text] [Related]
33. Elucidating the role of the FoxO3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells.
Yan F; Liao R; Farhan M; Wang T; Chen J; Wang Z; Little PJ; Zheng W
Biomed Pharmacother; 2016 Dec; 84():1538-1550. PubMed ID: 27881235
[TBL] [Abstract][Full Text] [Related]
34. Dracorhodin perchlorate induces apoptosis and G2/M cell cycle arrest in human esophageal squamous cell carcinoma through inhibition of the JAK2/STAT3 and AKT/FOXO3a pathways.
Lu Z; Lu C; Li C; Jiao Y; Li Y; Zhang G
Mol Med Rep; 2019 Sep; 20(3):2091-2100. PubMed ID: 31322237
[TBL] [Abstract][Full Text] [Related]
35. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
36. Anti-tumor activity of SL4 against breast cancer cells: induction of G
Wang LH; Jiang XR; Chen GL; Guo W; Zhang JY; Cui LJ; Li HH; Li M; Liu X; Yang JY; Wu CF
Sci Rep; 2016 Nov; 6():36486. PubMed ID: 27819344
[TBL] [Abstract][Full Text] [Related]
37. Protein kinase CK2 regulates AKT, NF-κB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia.
Quotti Tubi L; Canovas Nunes S; Brancalion A; Doriguzzi Breatta E; Manni S; Mandato E; Zaffino F; Macaccaro P; Carrino M; Gianesin K; Trentin L; Binotto G; Zambello R; Semenzato G; Gurrieri C; Piazza F
Leukemia; 2017 Feb; 31(2):292-300. PubMed ID: 27479180
[TBL] [Abstract][Full Text] [Related]
38. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
[TBL] [Abstract][Full Text] [Related]
39. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells.
Fang L; Wang H; Zhou L; Yu D
Toxicol Appl Pharmacol; 2011 Feb; 251(1):8-15. PubMed ID: 21092744
[TBL] [Abstract][Full Text] [Related]
40. Quinazoline based small molecule exerts potent tumour suppressive properties by inhibiting PI3K/Akt/FoxO3a signalling in experimental colon cancer.
Qazi AK; Hussain A; Khan S; Aga MA; Behl A; Ali S; Singh SK; Taneja SC; Shah BA; Saxena AK; Mondhe DM; Hamid A
Cancer Lett; 2015 Apr; 359(1):47-56. PubMed ID: 25554016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
